ClinicalTrials.Veeva

Menu

To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease

P

PharmaKing

Status and phase

Completed
Phase 4

Conditions

Chronic Liver Disease

Treatments

Drug: Placebo
Drug: Pennel
Drug: Legalon

Study type

Interventional

Funder types

Industry

Identifiers

NCT02347319
P2010-PN004

Details and patient eligibility

About

Purpose

  • To evaluate the efficacy of Biphenyl dimethyl dicarboxylate(DDB)/Garlic Oil in patients with elevated transaminase chronic liver disease.

Full description

Biphenyl dimethyl dicarboxylate (DDB) combined with garlic oil (pennel) has been used to treat chronic liver disease. A randomized, double-blind, active- and placebo-controlled clinical trial was conducted to investigate the efficacy, safety and quality of life in chronic liver disease patients.

Enrollment

262 patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients over 20years of age
  • Patients with more 60 ALT in screening period.
  • To evaluate ALT and AST at least three months.
  • Serum Transaminase abnormal(before 6months), chronic liver disease or fatty liver, liver disease medical treatment at more than 30days
  • Women of childbearing age get her consent for contraception, pregnancy urine test result negative.

Exclusion criteria

  • ALT>10UNL on screening period.
  • Current treatment on another clinical trial
  • Pregnancy or breastfeeding

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

262 participants in 3 patient groups, including a placebo group

Pennel
Experimental group
Description:
This group will treated with DDB 25mg/Garlic oil 50mg for 12 weeks.
Treatment:
Drug: Pennel
Legalon
Active Comparator group
Description:
This group will treated with Silymarin 140mg for 12 weeks.
Treatment:
Drug: Legalon
Placebo
Placebo Comparator group
Description:
This group will treated with Placebo for 12 weeks.
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems